FDA Approves Cymbalta for Chronic Musculoskeletal Pain
A drug used to treat depression, anxiety, fibromyalgia, and diabetic neuropathy has been approved by the FDA for a new use -- to treat chronic musculoskeletal pain, including pain caused by osteoarthritis and chronic low back pain.
Click here to read the full story.
The content has been reported and it will be reviewed by a moderator.
